Funder: Cancer Research Institute
Due Dates: January 15, 2026 (application submission deadline)
Funding Amounts: $1.25M over 5 years; up to 10% additional indirect costs to institution
Summary: Supports bold mid-career scientists with flexible, long-term funding to drive transformative research in cancer immunotherapy.
Key Information: No citizenship restrictions; applicants must meet specific tenure-track requirements.